Differential regulation of plasma obestatin and ghrelin by meal intake and the cholinergic system in lean, but not obese individuals

What Was Tested

Researchers studied Ghrelin in this randomized controlled trial publication.

Obestatin is cosecreted with and stemming from the same precursor as ghrelin and is apparently involved in energy metabolism.

Relatively little is known about the regulation of obestatin release.

Who Took Part

PubMed indexes the participants as adults, both men and women.

The researchers conducted a randomized, double-blind, placebo-controlled, crossover study with 4 study days in eight obese (body mass index >30 kg/m(2)) and eight matched lean (body mass index <25 kg/m(2)) healthy subjects (two males and six females per group) at a University Clinical Research Unit.

How the Study Was Run

The researchers set it up as a randomized, double-blind, placebo-controlled and crossover study.

Random assignment meant chance, not the researchers, decided who got Ghrelin and who got the comparison, which limits bias.

As a double-blind Ghrelin study, the assignments were hidden from both participants and investigators until the end.

A placebo (an inactive look-alike) gave the Ghrelin group a baseline to be compared against.

Each person switched between Ghrelin and the comparison at some point, usually with a gap in between.

What Was Measured

The subject headings attached to it are Atropine, Cholinergic Fibers, Eating, Ghrelin, Obesity, Parasympathetic Nervous System and Parasympatholytics.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Ghrelin.

Results are reported in around 5 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2010 (The Journal of clinical endocrinology and metabolism), a journal based in United States.

More context: the Ghrelin compound page, all human trials.